Tuesday, April 30, 2019

Lupin-Natco get USFDA nod to market generic hypertension drug

Lupin-Natco get USFDA nod to market generic hypertension drug The approval by the United States Food and Drug Administration (USFDA) is for marketing Bosentan tablets in the strengths of 62.5 mg and 125 mg, Lupin said in a statement.

from Moneycontrol Business News http://bit.ly/2ZDtkjQ

No comments:

Post a Comment

F&O Talk| Nifty extends losing streak for 4th week, bearish signals deepen: Sudeep Shah

The Nifty index is on a four-week losing streak, influenced by underwhelming Q1 earnings and global trade concerns. Nifty Bank outperformed ...